Assessing the Impact of Indiana Public Law 194 on Curbing the Concurrent Opioid Prescribing for Indiana Medicaid Enrollees

Simple item page
dc.contributor.authorVivas-Valencia, Carolina
dc.contributor.authorAdams, Nicole
dc.contributor.authorGriffin, Paul
dc.contributor.authorKong, Nan
dc.date.accessioned2023-05-11T18:31:53Z
dc.date.available2023-05-11T18:31:53Z
dc.date.issued2023-04-20
dc.description.abstractBackground: Several US states have introduced legislation to support the legitimate medical use of opioids while limiting misuse and diversion. One concern which has been addressed through legislation is preventing individuals from seeking opioid prescriptions concurrently from multiple providers. However, the impact of this legislation on the incidence of patients receiving concurrent prescriptions remains relatively unexplored. This study examines this phenomenon based on claims data from Medicaid enrollees and the enactment of legislation in Indiana. Methods: Indiana Medicaid claims data over the period of January 2014 to December 2019 were used to determine the changes in the percentage of individuals receiving opioid prescriptions from multiple providers within a 30-day period, that is, concurrent opioid prescription (COP) individuals. Indiana Medicaid enrollees with a diagnosis of opioid use disorder (OUD) receiving opioid prescriptions, that is, the OUD-group, were identified and separated from the enrollees without a diagnosis but receiving opioid prescriptions, that is, the non-OUD group. The mean percentages of COP individuals (with or without an OUD diagnosis) within the subset of individuals that received opioid prescriptions were compared before and after the passage of Indiana Public Law 194. Results: There were 5336 who met the criteria of COP individuals, and 2050 of those were in the OUD-group. In either group, there was a significant difference in the change in percentages (slope) before and after Indiana Public Law 194 passed. In addition, there was a significant decrease in the mean percentage of COP individuals in the non-OUD group, while the difference was not significant in the OUD group. Conclusion: Our study suggests that Indiana Public Law 194 had a positive impact on curbing COP. This study is limited by the level of details available from claims data and suggests additional studies to evaluate prescription use and prescribing practices are warranted.en_US
dc.description.departmentBiomedical Engineering and Chemical Engineering
dc.identifier.citationVivas-Valencia, C., Adams, N., Griffin, P., & Kong, N. (2023). Assessing the Impact of Indiana Public Law 194 on Curbing the Concurrent Opioid Prescribing for Indiana Medicaid Enrollees. Substance Abuse: Research and Treatment, 17, 1-7. doi:10.1177/11782218231168722en_US
dc.identifier.issn1178-2218
dc.identifier.otherhttps://doi.org/10.1177/11782218231168722
dc.identifier.urihttps://hdl.handle.net/20.500.12588/1840
dc.language.isoen_USen_US
dc.publisherSAGE Publicationsen_US
dc.rightsAttribution-NonCommercial 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/us/*
dc.subjectprescription opioidsen_US
dc.subjectperception drug monitoring programsen_US
dc.subjectconcurrent prescriptionsen_US
dc.subjectlegislationen_US
dc.subjectreimbursement claims dataen_US
dc.subjectMedicaiden_US
dc.titleAssessing the Impact of Indiana Public Law 194 on Curbing the Concurrent Opioid Prescribing for Indiana Medicaid Enrolleesen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Vivas-Valencia 2023 - Assessing the Impact of Indiana Public Law 194 on Curbing the Concurrent Opioid Prescribing for Indiana Medicaid Enrollees.pdf
Size:
5.46 MB
Format:
Adobe Portable Document Format
Description:
Download

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.86 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Margie and Bill Klesse College of Engineering and Integrated Design Faculty Research